Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas

Cancer. 2001 Sep 1;92(5):1347-8. doi: 10.1002/1097-0142(20010901)92:5<1347::aid-cncr1456>3.0.co;2-0.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Feasibility Studies
  • Female
  • Humans
  • Leiomyosarcoma / drug therapy*
  • Male
  • Middle Aged
  • Pilot Projects

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • etaracizumab